Radiolabeling and In-Silico Study of 131I-(4-fluorobenzoyl-3-methylthiourea) as Radiopharmaceuticals for Breast Cancer Theranostics. Valensi. 2024;10(1):27-44. doi:10.15408/jkv.v10i1.34258